Market Research Logo

United States Anesthesia Drugs Market & Forecast

United States Anesthesia Drugs Market & Forecast

United States Anesthesia Market is expected to be more than US$ 4 Billion by 2022. This growth is driven by increasing incidence of cardiovascular cases, growing old age population and rising number of urgent surgeries in United States. Private as well as public health insurers also help to boost this market as they consider anesthetic products in their reimbursement policy.

General Intravenous Anesthesia is the Leading Segments in the United States Anesthesia Market

General intravenous anesthesia is the leading segments in the United States Anesthesia Market. Propofol, Benzodiazepines Class, Fospropofol Disodium, Ketamine, Methohexital Sodium, Pentobarbital, Etomidate and Fentanyl are commonly used general intravenous anesthesia in the United States. Among these anesthesia, Propofol and Benzodiazepines Class are the leading anesthesia drugs which hold more than 75 percent combined market share in 2016.

Major Anesthesia Drug’s Manufacturers are continuously losing their Sales in United Sates

In the United States anesthesia drugs market several players are selling their products. Most of the anesthesia drugs sale are in generic form as it is available in the low cost. However all major drugs manufactures such as AstraZeneca, AbbVie , Endo Healthcare etc. anesthesia products sales are turning down continuously. Only Baxter International anesthesia drugs sales are growing in the United States market.

United States Anesthesia Drugs Market & Forecast is the 2nd edition report on United States Anesthesia Market published by Renub Research. This 127 page report with 55 Figures and 16 Tables provides a detailed analysis of local and general anesthesia drugs market, health insurers’ anesthesia reimbursement policies, eligibility criteria and reimbursement methods in United States. This report has been studied from 8 viewpoints.

1. United Sates Anesthesia Market
2. United Sates Anesthesia Drugs Share Analysis
3. General Anesthesia Market
4. Local Anesthesia Market
5. Anesthesia Reimbursement Policy by Health Insurance Companies (Private & Public)
6. Major Companies Anesthesia Sales
7. United States Anesthesia Market Drivers
8. United States Anesthesia Market Challenges

General Intravenous Anesthetic Drugs Market has been further divided into

1. Propofol Market (2011 – 2022)
2. Benzodiazepines Class (Diazepam and Midazolam) (2011 – 2022)
3. Fospropofol Disodium (2011 – 2022)
4. Ketamine (2011 – 2022)
5. Methohexital Sodium (2011 – 2022)
6. Pentobarbital (2011 – 2022)
7. Etomidate (2011 – 2022)
8. Fentanyl (2011 – 2022)

United States Local Anesthetic Market has been further divided into

1. Articane (2011 – 2022)
2. Bupivacaine (2011 – 2022)
3. Lidocaine (2011 – 2022)
4. Mepivacaine (2011 – 2022)
5. Prilocaine (2011 – 2022)

Key Players Sales in United States Anesthetic Drugs Market

1. Baxter International Inc (2011 – 2022)
2. Endo Health Solutions Inc (2011 – 2022)
3. AbbVie (2011 – 2022)
4. AstraZeneca (2011 – 2022)

This report provides the answer of following questions

• Which one is the leading market (Local anesthesia or general Anesthesia) in the United States Anesthesia market?
• Which is the leading local anesthesia drug in United States Local Anesthesia Market?
• Which is the leading General anesthesia drug in United States General Anesthesia Market?
• What is the market size of each anesthesia drugs during 2011 – 2022?
• What is the reimbursement policy on anesthetic services in the United States?
• What are the anesthesia drugs sales situations in United States for key anesthesia players?
• What is the reimbursements policy in United States for Anesthesia by Private and Public Insurers


  • Executive Summary
  • United States Anesthesia Drugs Market (2011 – 2022)
  • United States Anesthesia Drugs Market Share & Forecast (2011 – 2022)
    • United States Anesthesia Drugs Market Share & Forecast by Type (2011 – 2022)
    • United States General Intravenous Anesthesia Drugs Market Share & Forecast (2011 – 2022)
    • United States Local Anesthesia Drugs Market Share & Forecast (2011 – 2022)
    • United States Anesthesia Drugs Market Share & Forecast by Company (2011 – 2022)
  • By Type – United States Anesthesia Drugs Market (2011 – 2022)
    • United States General Inhalation Anesthesia Drugs Market (2011 – 2022)
    • United States General Intravenous Anesthesia Drugs Market (2011 – 2022)
    • United States Local Anesthesia Drugs Market (2011 – 2022)
  • By Drugs – United States General Intravenous Anesthesia Drugs Market (2011 – 2022)
    • United States Propofol Market (2011 – 2022)
    • United States Benzodiazepines Class (Diazepam and Midazolam) Market (2011 – 2022)
    • United States Fospropofol Disodium Market (2011 – 2022)
    • United States Ketamine Market (2011 – 2022)
    • United States Methohexital Sodium Market (2011 – 2022)
    • United States Pentobarbital Market (2011 – 2022)
    • United States Etomidate Market (2011 – 2022)
    • United States Fentanyl Market (2011 – 2022)
  • By Drugs – United States Local Anesthesia Drugs Market (2011 – 2022)
    • United States Articaine Market (2011 – 2022)
    • United States Bupivacaine Market (2011 – 2022)
    • United States Lidocaine Market (2011 – 2022)
    • United States Mepivacaine Market (2011 – 2022)
    • United States Prilocaine Market (2011 – 2022)
  • Key Players Profile in United States Anesthesia Drugs Market
    • Baxter International Inc. Anesthesia Drugs Sales & Forecast (2011 – 2022)
    • Endo Health Solutions Inc. Anesthesia Drugs Sales & Forecast (2011 – 2022)
    • AbbVie Anesthesia Drugs Sales & Forecast (2011 – 2022)
    • AstraZeneca Anesthetic Drugs Sales (2009 – 2011)
  • United States Anesthesia market Merger & Acquisition (M&A)
    • Table United States – Anesthesia Market Merger & Acquisitions (M&A), Jan 2016 – March 2017
  • United States Anesthesia Reimbursement Policy - Private Health Insurance Providers
    • Aetna International
    • Coventry Health Care
      • Table Coventry Health Care - Anesthesia Modifiers, 2016
    • Anthem Blue Cross and Blue Shield
    • Blue Cross and Blue Shield of Texas
      • Table Blue Cross and Blue Shield of Texas - Physical Status Modifiers, 2017
      • Table Blue Cross and Blue Shield of Texas - Qualifying Circumstances, 2017
      • Table Blue Cross and Blue Shield of Texas - Modifier Information Billed by an Anesthesiologist, 2017
      • Table Blue Cross and Blue Shield of Texas - Modifier Information Billed by a CRNA, 2017
      • Table Blue Cross and Blue Shield of Texas - Anesthesia Modifier Reimbursement
    • UnitedHealthcare
      • Table UnitedHealthcare Community – Modifiers, 2017
      • State Exceptions
  • United States Anesthesia Reimbursement Policy – Public Health Insurance Providers
    • Medicare
      • Table Medicare - Reimbursement Formulas
      • Table Medicare - General and Monitored Anesthesia Care
      • Table Medicare - Anesthesia Modifiers, 2017
    • MDWise
      • Table MDwise –Type of Service & PA Requirement
      • Table MDwise - Anesthesia Time Table, 2017
      • Table MDwise - Qualifying Circumstances, 2017
      • Table MDwise - Status Modifiers, 2017
  • United States Anesthesia Drugs Market – Growth Drivers
    • Growing Demand for Anesthesia Service
    • Rise in Ageing Population & Prevalence of Cardiovascular Disease in United States
      • Rise in Ageing Population
        • Table United States – Cardiovascular Disease Prevalence (Percent), 2010,2015,2020,2025, 2030
  • United States Anesthesia Drugs Market – Challenges
    • Un-match Anesthesia Providers in United States
    • Shortage of Anesthesia Drugs in United States

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report